Related Experiment Video
Updated: Aug 7, 2026
09:44
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
Published on: March 3, 2015
Regulation of UDP glucuronosyltransferase genes
P I Mackenzie1, P A Gregory, D A Gardner-Stephen
1Department of Clinical Pharmacology, Flinders Medical Research Institute, Flinders University, Bedford Park, SA 5042, Australia. Peter.Mackenzie@flinders.edu.au
Current Drug Metabolism
|May 29, 2003
Summary
Individual differences in UDP glucuronosyltransferase (UGT) levels, crucial for drug metabolism, are linked to gene expression. Understanding UGT regulation is key to personalized medicine and drug response.
Area of Science:
- Biochemistry
- Pharmacology
- Genetics
Background:
- UDP-glucuronosyltransferases (UGTs) are critical enzymes for xenobiotic and endogenous compound metabolism via glucuronidation.
- Significant inter-individual variability exists in UGT expression levels across tissues, impacting chemical response.
- The molecular mechanisms underlying these UGT expression differences remain largely unknown.
Purpose of the Study:
- To explore the regulatory mechanisms governing UDP-glucuronosyltransferase (UGT) gene expression.
- To identify key transcription factors and signaling pathways involved in controlling UGT levels.
Main Methods:
- Analysis of gene expression data.
- Identification of transcription factor binding sites.
- Review of literature on UGT regulation.
Main Results:
- Constitutive UGT expression is regulated by transcription factors including Hepatocyte Nuclear Factor 1, CAAT-Enhancer Binding Protein, Octamer transcription Factor 1, and Pbx2.
- UGT gene expression is further modulated by external factors like hormones, drugs, and foreign chemicals.
- Proteins such as the Ah receptor, CAR, PXR, and stress-response transcription factors mediate these modulations.
Conclusions:
- Differential UGT gene expression is the likely cause of inter-individual differences in UGT content.
- Multiple transcription factors and signaling pathways contribute to the complex regulation of UGTs.
- Further research into UGT regulation can inform personalized medicine and xenobiotic metabolism studies.
Related Concept Videos
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
01:23Regulation of Expression at Multiple Steps
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
01:14Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
01:24Phase II Reactions: Glucuronidation
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...